Publication | Closed Access
ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosis
20
Citations
31
References
2020
Year
InflammationMolecular PharmacologyMetabolic SyndromeMolecular PhysiologyHepatologyMedicineLiver PhysiologyPathologyMetabolic RegulationHepatic FibrosisHepatotoxicityLiver DiseaseHepatology FibrosisGlucolipid MetabolismFatty Liver DiseasePharmacologyDrug-induced Liver InjuryHealth Sciences
| Year | Citations | |
|---|---|---|
Page 1
Page 1